home / news releases


Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

Now Trending

Company Name:Incannex Healthcare Limited
Stock Symbol:IXHL
Market:NASDAQ
Website:incannex.com.au

Menu

IXHL IXHL Quote IXHL Short IXHL News IXHL Articles IXHL Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search News Releases

ARBK - Argo Blockchain PLC Announces Loan Extension

Extension of Galaxy Loan LONDON, UNITED KINGDOM / ACCESSWIRE / July 1, 2024 / Argo Blockchain plc, (LSE:ARB)(NASDAQ:ARBK), a global leader in cryptocurrency mining using predominantly renewable energy, announces the extension of its loan with Galaxy Digital Holdings Ltd. ("Galaxy") through ...

NYXH - Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024 , 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the develop...

ACN - Accenture Completes Acquisition of OPENSTREAM HOLDINGS

Accenture (NYSE: ACN) has completed the acquisition of OPENSTREAM HOLDINGS and its subsidiaries, Open Stream and Neutral , to help clients reinvent their businesses with advanced digital technologies and become truly data-driven. Terms of the acquisition were not disclosed. This p...

MESO - Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week

NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today confirmed that it will file its Biologics License Application (BLA) for approval of Ryoncil ® (remestemcel-L) in the treat...

MEOBF - Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week

NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today confirmed that it will file its Biologics License Application (BLA) for approval of Ryoncil ® (remestemcel-L) in the treat...

ORPOF - OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal 'Blood'

OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’ Nantes, France – July 1 st , 2024 – 7:30 am CET – OSE Immunotherapeutics SA (ISIN: FR...

VOO - Wishing You'd Bought Nvidia? Surprise! You May Already Own It!

2024-07-01 01:29:00 ET This article first appeared on our U.S. website and was written by Selena Maranjian. If you’ve been hearing a lot about semiconductor company Nvidia ( NASDAQ: NVDA ) in recent months and you’re not sure why, check out its retu...

VGT - Wishing You'd Bought Nvidia? Surprise! You May Already Own It!

2024-07-01 01:29:00 ET This article first appeared on our U.S. website and was written by Selena Maranjian. If you’ve been hearing a lot about semiconductor company Nvidia ( NASDAQ: NVDA ) in recent months and you’re not sure why, check out its retu...

SPY - Wishing You'd Bought Nvidia? Surprise! You May Already Own It!

2024-07-01 01:29:00 ET This article first appeared on our U.S. website and was written by Selena Maranjian. If you’ve been hearing a lot about semiconductor company Nvidia ( NASDAQ: NVDA ) in recent months and you’re not sure why, check out its retu...

XLK - Wishing You'd Bought Nvidia? Surprise! You May Already Own It!

2024-07-01 01:29:00 ET This article first appeared on our U.S. website and was written by Selena Maranjian. If you’ve been hearing a lot about semiconductor company Nvidia ( NASDAQ: NVDA ) in recent months and you’re not sure why, check out its retu...

Previous 10 Next 10